Parvus Therapeutics Inc

Parvus Therapeutics Inc. operates as a biopharmaceutical company. The Company develops novel proprietary pMHC nanomedicine drug candidates as treatments for patients who suffer from autoimmune disease. Parvus Therapeutics serves customers in the United States.